Issue Date: October 2, 2017
Brammer Bio expands capacity
Brammer Bio has undertaken expansions at its early-clinical-phase facility in Alachua, Fla., and its Phase III and commercial facility in Cambridge, Mass. Investments at the two facilities total $40 million and include a range of Pall Life Sciences bioreactors to bolster cell and gene therapy manufacturing.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society